Corrigendum to ‘Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making’ The American Journal of Medicine 136:03 (2023); 260-269.e7 (The American Journal of Medicine (2023) 136(3) (260–269.e7), (S0002934322008749), (10.1016/j.amjmed.2022.10.021))

Andrew M. Freeman, Subha V. Raman, Monica Aggarwal, David J. Maron, Deepak L. Bhatt, Purvi Parwani, John Osborne, James P. Earls, James K. Min, Jeroen J. Bax, Michael D. Shapiro

Research output: Contribution to journalComment/debate

Abstract

The authors regret that an error appeared in Table 3: Stage 1 should read “High-intensity statin: (Rosuvastatin 40mg QD/Atorvastatin 80mg QD)”. The corrected Table appears on the following page. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)720-721
Number of pages2
JournalAmerican Journal of Medicine
Volume136
Issue number7
DOIs
StatePublished - Jul 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making’ The American Journal of Medicine 136:03 (2023); 260-269.e7 (The American Journal of Medicine (2023) 136(3) (260–269.e7), (S0002934322008749), (10.1016/j.amjmed.2022.10.021))'. Together they form a unique fingerprint.

Cite this